Imegli Tablet 500 mg contains Imeglimin Hydrochloride, a novel oral antihyperglycemic agent indicated for the management of type 2 diabetes mellitus. Imegli works by improving both insulin secretion and insulin sensitivity, addressing multiple pathophysiological defects in type 2 diabetes. Its unique dual mechanism of action makes it a promising therapy for patients who need effective glycemic control, either as monotherapy or in combination with other antidiabetic medications.

Type 2 diabetes is characterized by insulin resistance, impaired insulin secretion, and elevated blood glucose levels. Prolonged hyperglycemia can lead to complications including cardiovascular disease, nephropathy, neuropathy, and retinopathy. Imegli Tablet 500 mg helps normalize blood sugar levels, improving patient outcomes and reducing the risk of diabetes-related complications.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each tablet contains:

• Imeglimin Hydrochloride 500 mg – a novel oral antidiabetic agent

The tablet also includes excipients that ensure stability, bioavailability, and ease of administration.

Mechanism of Action

Imeglimin Hydrochloride has a unique dual mechanism of action:

• Enhances insulin sensitivity: Improves the body’s response to insulin in peripheral tissues such as muscle and liver, facilitating better glucose uptake and utilization.

• Stimulates insulin secretion: Enhances glucose-dependent insulin secretion from pancreatic beta cells, promoting physiological glucose control without causing excessive insulin release.

• Mitochondrial modulation: Imeglimin optimizes mitochondrial function, reducing oxidative stress and improving cellular energy metabolism, which is often impaired in type 2 diabetes.

This dual effect on insulin secretion and sensitivity addresses two major defects of type 2 diabetes, helping to lower fasting and postprandial blood glucose levels safely.

Indications

Imegli Tablet 500 mg is indicated for:

• Management of type 2 diabetes mellitus in adults

• Patients who require improved glycemic control when diet and exercise alone are insufficient

• Use as monotherapy or in combination with other oral antidiabetic agents, such as metformin, DPP-4 inhibitors, or SGLT2 inhibitors

Benefits

• Effectively lowers fasting and postprandial blood glucose levels

• Addresses both insulin resistance and impaired insulin secretion

• Reduces the risk of long-term diabetes-related complications

• Can be combined safely with other antidiabetic medications

• Provides a novel therapeutic option for patients inadequately controlled on conventional therapy

Dosage and Administration

• Adults: The recommended dose is 500 mg twice daily, preferably with meals, or as prescribed by a healthcare professional.

• Administration: Swallow the tablet with water; it can be taken with or without food.

• Monitoring: Regular blood glucose monitoring and periodic HbA1c assessment are recommended to evaluate therapeutic response.

Precautions

• Use with caution in patients with renal or hepatic impairment

• Monitor for signs of hypoglycemia when combined with insulin or insulin secretagogues

• Not recommended for type 1 diabetes or diabetic ketoacidosis

• Inform the healthcare provider about all medications to avoid potential drug interactions

• Use during pregnancy or breastfeeding only under medical supervision

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Imegli Tablet 500 mg is generally well tolerated. Mild side effects may include:

• Gastrointestinal discomfort such as nausea, diarrhea, or abdominal pain

• Headache or dizziness

• Rare hypoglycemia, especially when combined with other glucose-lowering agents

Most adverse effects are mild and transient.

Storage

Store below 30°C in a cool, dry place, protected from light. Keep out of reach of children.

Imegli Tablet 500 mg is a safe and effective option for managing type 2 diabetes mellitus, improving glycemic control, and reducing the risk of long-term diabetic complications.